N30 Pharma Announces Completion of Phase 1 Clinical Studies Wi...(yheadquartered in Boulder Colorado....),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201
Date:5/5/2008
y headquartered in Boulder, Colorado.
'/>"/>
| SOURCE N30 Pharma Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
2. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
3. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
4. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
5. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
6. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
7. ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
10. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
11. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Post Your Comments:
(Date:11/23/2009)...LightSciencesOncology,Inc.(LSO)todayannouncedtheel...newlycreatedseatonitsboardofdirectors.Mr.Seddighis...ies,includingElekta,tomarketleadership. ,, "The...nbusinessdevelopmenttotheboard,"saidLSO,sChairmano...ncer-therapybusinessdevelopment.Hehasoverseentheem...
(Date:11/23/2009)...e-FirstCall/-- LexiconPharmaceuticals,Inc. (Nasdaq...e2clinicalstudywith LX1031 inpatientswithnon-const...tGASTRO2009inLondonthisweek.Resultsfromthestudy,wh...bepresentedbyDr. PhilipM.Brown ,Lexicon,sseniorvic...t2:30pmlocaltimeatthesessionentitled,"Therapeutici...
(Date:11/23/2009)...endsResearchGroup,Inc.releasedWave2ofits LaunchTr...asesyndicatedmarketresearchprojecttrackingthelaunc...sixmonthsofproductavailability.Eachwaveofthereport...ogistsandqualitativeinformationfromasubsetof15.The...reasonstouse,typicalpatienttypes,productperception...
Breaking Medicine Technology:Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2McGraw Hill Medical Wins 2009 BMA Medical Book of the Year Award 57407 1McGraw Hill Medical Wins 2009 BMA Medical Book of the Year Award 57407 2Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 1Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 2The Simmons Firm to Host Midwest Asbestos Litigation Conference 57399 1The Simmons Firm to Host Midwest Asbestos Litigation Conference 57399 2[0] Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors[0] Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009[0] Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use
...ved All Three Key Lipids and Had Reported Safet..., CHICAGO, March 31 New data from two Phase III,...problems, Abbott,s,ABT-335 combined with two commo...in), significantly improved three key lipids -- LD...cholesterol -- compared to the,corresponding monot...
...twork, Inc. Surpasses 2007 ...celerated Community,Oncology Research Network, Inc...ork, announced today that its Contract Research Or... over the past 12 months. ACORN,s CRO,provides the... clinical,trial design to site selection to the re...
Other Medicine Technology:Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL 2Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL 3ACORN's Oncology-focused Contract Research Organization Exceeds Projections 2(Date:11/23/2009)...ramSupportsFutureLeadersinSTEMFields ,, Schol... n ceS c holars.org ,, WASHINGTON,...ncountusin.Withourcommunity,foundation,andcorporat...ovate,"saidAdolphP.Falcon,SeniorVicePresidentofthe...hiteHousemeetingtodaywherePresidentObamaannouncedt...
(Date:11/23/2009)...Newswire-USNewswire/--SouthamptonHospitalannounced...fundanewEmergencyDepartment.Thegiftisthelargestint...tdoubletheexistingspaceandgreatlyexpanditsdelivery...kofLongIsland. ,, ScheduledforcompletionbyMay20...provideacentralizedtraumanurses,stationandtriagear...
(Date:11/23/2009)...thing, protein may be the cause , , MOND...say they,ve identified a protein that causes nasa... people with chronic sinusitis. , The condition...constant irritation and swelling of the nasal pass...ue -- can block the sinus passages and make it dif...
(Date:11/23/2009)...tudent Jennifer Heys wants to make her message cle...mmunities about contraception. , Heys, research...bear more children, was read by experts from all o...ational Conference on Family Planning in Kampala, ...lic Health, spent six months interviewing 421 peop...
(Date:11/23/2009)...wire/--ThousandsofpeoplewithiPhoneshavealreadydown...hdiabetesbettermanagetheirdiseasethroughabetterund...bettermanagetheirbloodsugar.Nowit,sbecomeeveneasie... ,, RocheDiabetesCare,themakeroftheACCU-CHEK...ms,haspartneredwithMYLEstoneHealth,thedeveloperofG...
Breaking Medicine News(10 mins):Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Southampton Hospital Receives $5 Million Gift for New Emergency Department 2Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 3[1] Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education[0] Southampton Hospital Receives $5 Million Gift for New Emergency Department[0] Research Yields Clues to Severe Form of Sinusitis[0] AIDS research reveals a lack of family-planning programs in Uganda[0] ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com
...ir search for a cure for diabetes. A new study don...velop into insulin //producing pancreatic islet ce...tients with diabetes.
The latest research is a ...hat accomplishment. David Nathan, M.D., director o...
...500 others who ate at a Chi-Chi's Mexican restaura...f hepatitis A in U.S.// history, making people so ...cinations and no longer eating out.
Health i... 25 miles northwest of Pittsburgh.
``We're ve...
... anti-inflammatory drugs (NSAIDs) before and after...in from the procedure.//
Researchers from Rus...patients who were undergoing knee replacement surg... each day for five days after surgery, and 25 mill...
..., who say women will now have to talk seriously wi...ly aspirin.//
Pancreatic cancer affects only 31...its victims within three years.
The study of 88... expected that aspirin would protect against pancr...
...k patients with high density lipoprotein may rever...rs from the Cleveland Clinic injected patients wit...olesterol, which naturally removes fatty buildups ... they got the idea for their study after observing...
...4 people remains unknown. Scientists believe peopl... infected by another source.//
"You might want...ggested Dr. Robert Shope, an expert on emerging di...f a leap of faith that it will transmit to humans....
Other Medicine News:Health News:Islets May Lead to Diabetes Cure 2Health News:Aspirin usage linked with pancreatic cancer 2Health News:Some pets found to be SARS carriers 2...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |